quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:43:44·883d
NEWSRelease
AgileThought Inc. logo
Alterity Therapeutics Limited logo
Eiger BioPharmaceuticals Inc. logo
+3

Dow Surges 150 Points; US Jobless Claims Decline Sharply

AGIL· AgileThought Inc.ATHE· Alterity Therapeutics LimitedEIGR· Eiger BioPharmaceuticals Inc.GES· Guess? Inc.NOGN· Nogin Inc.SPRC· SciSparc Ltd.
Consumer DiscretionaryHealth CareTechnology
Original source

Companies

  • AGIL
    AgileThought Inc.
    Consumer Discretionary
  • ATHE
    Alterity Therapeutics Limited
    Health Care
  • EIGR
    Eiger BioPharmaceuticals Inc.
    Health Care
  • GES
    Guess? Inc.
    Consumer Discretionary
  • NOGN
    Nogin Inc.
    Technology
  • SPRC
    SciSparc Ltd.
    Health Care

Recent analyst ratings

  • Aug 21GESUpdateTelsey Advisory Group$16.75
  • Mar 26GESUpdateTelsey Advisory Group$13.00
  • Feb 3ATHEUpdateThe Benchmark Company-
  • Dec 12ATHEUpdateMaxim Group$8.00
  • Nov 27GESUpdateTelsey Advisory Group$18.00
  • Aug 29GESUpdateTelsey Advisory Group$21.00

Related

  • PR2d
    Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
  • SEC2d
    SEC Form 6-K filed by Alterity Therapeutics Limited
  • SEC3d
    SEC Form 6-K filed by Alterity Therapeutics Limited
  • SEC4d
    SEC Form 6-K filed by Alterity Therapeutics Limited
  • SEC4d
    SEC Form 6-K filed by Alterity Therapeutics Limited
  • PR7d
    Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
  • SEC7d
    SEC Form 6-K filed by Alterity Therapeutics Limited
  • PR8d
    Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022